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Abstract 
Parasitic helminths evade, skew and dampen human immune responses through numerous 
mechanisms. Such effects will likely have consequences for HIV-1 transmission and disease 
progression. Here we analyzed the effects that soluble egg antigen (SEA) from Schistosoma 
mansoni had on modulating HIV-1 infection and cytokine/chemokine production in vitro. We 
determined that SEA, specifically through kappa-5, can potently bind to DC-SIGN and 
thereby blocks DC-SIGN mediated HIV-1 trans-infection (P<0.05) whilst not interfering 
with cis-infection. DCs exposed to SEA whilst maturing under Th2 promoting conditions, 
will upon co-culture with naïve T-cells induce a T-cell population that was less susceptible to 
HIV-1 R5 infection (P<0.05) compared to DCs unexposed to SEA, whereas HIV-1 X4 virus 
infection was unaffected. This was not observed for DCs exposed to SEA while maturing 
under Th1 or Th1/Th2 (Tmix) promoting conditions. All T-cell populations induced by SEA 
exposed DCs demonstrate a reduced capacity to produce IFN-γ and MIP-1β. The infection 
profile of T-cells infected with HIV-1 R5 was not associated with down-modulation of CCR5 
cell surface expression. We further show that DCs maturing under Tmix conditions exposed to 
plant recombinant omega-1 protein (rω-1), which demonstrates similar functions to natural ω-
1, induced T-cell populations that were less sensitive for HIV-1 R5 infection (P<0.05), but 
not for X4 virus infection. This inhibition associated again with a reduction in IFN-γ and 
MIP-1β expression, but additionally correlated with reduced CCR5 expression. We have 
shown that SEA parasite antigens and more specifically rω-1 can modulate HIV-1 infectivity 
with the potential to influence disease course in co-infected individuals.   
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Author summary 
Parasitic helminths have developed a number of strategies to evade, skew and dampen human 
immune responses. Such effects will likely have consequences for HIV-1 transmission and 
disease progression. Here we analyzed the effect that soluble egg antigen (SEA) from 
Schistosoma mansoni had on HIV-1 infection in vitro. We determined that SEA, through 
kappa-5, can potently block DC-SIGN mediated HIV-1 trans-infection of CD4
+
 T-
lymphocytes, but not block cis-infection. Dendritic cells (DC) exposed to SEA during 
maturation under Th2 skewing conditions, induce T-cell populations that are less susceptible 
to HIV-1 R5 infection compared to cells induced by unexposed DCs. HIV-1 X4 infection was 
unaffected. This restricted infection profile was not associated with down-modulation of 
CCR5 surface expression or observed differences in cytokine/chemokine production. Using 
recombinant omega-1, an abundant component of SEA, HIV-1 R5 infection was similarly 
inhibited with no effect on HIV-1 X4 infection levels. Hence SEA possesses antigens, 
namely omega-1, that can modulate HIV-1 infection and potentially influence disease course 
in co-infected individuals. 
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Introduction 
Humans encounter numerous pathogens throughout their life-time, encompassing bacteria, 
fungi, parasites and viruses with many infections occurring concomitantly. Since CD4
+
 T-
lymphocytes are the main cell-type infected with human immunodeficiency virus type 1 
(HIV-1), the immune responses mounted against the array of co-infecting pathogens will 
likely influence HIV-1 transmission and disease progression. Helminthic parasites such as 
Schistosoma mansoni (S. mansoni) are pertinent in this context, due to their ability to evade, 
dampen and skew the human immune system including the modulation of CD4
+
 T-
lymphocyte responses. Moreover, many areas endemic for S. mansoni infection have high 
HIV-1 prevalence rates indicating that co-infection is likely. 
Cells are infected with HIV-1 through the initial binding of its trimeric gp120 envelope 
protein to CD4, after which it interacts with numerous chemokine receptors, typically CCR5 
or CXCR4, and undergoes entry [1]. CCR5 using viruses (R5) are those predominantly 
transmitted, later in disease in approximately 50% of individuals the virus switches to 
utilizing CXCR4 (X4) as a co-receptor [2]. Following transmission the virus rapidly 
disseminates to lymph nodes and especially to the gut associated lymphoid tissue (GALT). 
The GALT is a major reservoir for CD4
+
CCR5
+
 memory T-cells and approximately 80% of 
these cells are lost in the first weeks following HIV-1 infection [3,4]. Direct infection of cells 
via the CD4 molecule and co-receptors is termed cis-infection. An array of C-type lectins 
(CLR) expressed on myeloid cell lineages have been shown to successfully capture HIV-1 
and pass the virus to activated CD4
+
 T-cells, referred to as trans-infection [5]. One such 
lectin known to strongly support trans-infection is dendritic cell specific ICAM3-grabbing 
non-integrin (DC-SIGN) which is expressed to high levels on dendritic cells (DCs). This 
molecule has been implicated in supporting HIV-1 transmission as well as virus 
dissemination [5,6]. DC-SIGN is known to bind many glycosylated structures including a 
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large array of pathogen antigens as well as numerous host proteins found in bodily secretions 
[7-10]. Indeed, these molecules have the capacity to interfere with HIV-1 trans-infection.  
CD4
+
 effector memory Thelper (Th) cells consist of three major subsets; Th1 cells 
induced by viral infections, Th2 cells induced by parasitic infections and Th17 cells induced by 
bacterial and fungal infections [11]. Remarkably, expression of HIV-1 co-receptors is not 
directly linked to the HIV-1 susceptibility of these cells. For instance, Th1 cells express high 
levels of CCR5 but also produce MIP-1α (CCL3), MIP-1β (CCL4) and RANTES (regulated 
upon activation normal T-cell expressed and secreted) (CCL5), the natural ligands for CCR5, 
thereby limiting R5 infection in these cultures [12,13]. Contrary, Th2 cells express lower levels 
of CCR5 but due to the limited production of MIP-1α, MIP-1β and RANTES these cultures 
have been shown to be infected with HIV-1 more easily [12,13]. This generalized view that 
Th2 cells are more susceptible to HIV-1 infection than Th1 cells is no longer supported. In a 
review by Mariana et al. it was stated that HIV-1 susceptibility of CD4
+
 T-cells varied 
dependent on the in vitro stimulation of these cells [14]. More recent studies have correlated 
pathogen specific CD4
+
 T-cell phenotypes to HIV-1 susceptibility. Cytomegalovirus (CMV) 
and Mycobacterium tuberculosis (Mtb) infections both result in the induction of Th1 cells 
[15,16]. However, the Mtb specific T-cells are lost early during HIV-1 infection while the 
CMV specific T-cells are lost later in disease [17]. This discrepancy was explained by 
differences in cytokine expression profiles, where Mtb specific cells possess a high IL-2 and 
low MIP-1β expression pattern, the reverse phenotype was observed in CMV specific CD4+ T-
cells [17]. Human papilloma virus specific CD4
+
 T-lymphocytes have also been shown to be 
lost early after HIV-1 infection [18,19].  
Helminths, including S. mansoni, are known to skew immune responses towards a Th2 
phenotype, which according to the above hypothesis would be detrimental to those 
individuals co-infected with HIV-1 [20,21]. This has led to the assumption that treating S. 
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mansoni in co-infected individuals would be beneficial for their HIV-1 disease. Clear 
epidemiological evidence to-date is lacking, as treatment studies have been reporting 
contradictory findings [22]. A treatment program in Ethiopia found that deworming S. 
mansoni infected HIV-1 patients led to a decrease in viral loads [23], whilst another study in 
Uganda reported the opposite [24]. Similar inconsistencies have been found for other markers 
associated with HIV-1 disease progression reviewed in [21] with only one exception. Women 
infected with S. haematobium and who have egg induced lesions in their genital tract were 
found to be at higher risk of HIV-1 infection [25,26]. 
In S. mansoni infections the eggs play a crucial role in disease as they induce lesions 
and skew CD4
+
 T-lymphocyte responses. An adult S. mansoni pair typically lay up to 300 
eggs a day which migrate to the gut lumen in order to be expelled [27]. One of the best 
studied antigen mixtures of S. manoni is soluble egg antigen (SEA) which is an extract 
derived from homogenized eggs and consists of hundreds of proteins of which many are 
glycosylated [28]. SEA has accordingly been shown to bind many glycan receptors including 
DC-SIGN, mannose receptor (MR) and macrophage galactose type-lectin (MGL) [28,29]. 
Through binding to these receptors SEA alters the DCs response to TLR4 ligand, LPS 
(lipopolysaccharide) and TLR3 ligand PolyI:C [30]. Albeit, SEA itself cannot fully mature 
immature DC (iDCs), while antigen processing is similar to LPS matured DCs [31]. 
Furthermore, SEA exposed DCs are known to induce Th-cell responses that are skewed 
towards a Th2 phenotype, even when a Th1 cell response is required [32]. Recently it has 
been demonstrated that omega-1 (ω-1), one of SEA’s main components, is able to drive Th2 
cell responses [33-35]. Omega-1 is a member of the T2 RNase family which enters the cell 
through binding MR and subsequently degrades cellular mRNA and rRNA products. Both the 
RNase activity and the glycan group are essential for Th2 skewing [33].  
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Infection with either S. mansoni or HIV-1 has major implications for the host, due to 
the longevity of infection and extent of damage these pathogens cause to the immune system. 
The complex pathogen interactions encountered in co-infected individuals makes it difficult 
to determine the effect of S. mansoni on HIV-1 infection. Consequently, our study focused on 
the effects of SEA on HIV-1 infection, where we specifically address whether SEA can 
interfere with cis- or trans-infection of CD4
+
 T-lymphocytes as well as whether the effects 
exerted by SEA on DC maturation, can modulate the T-cell population’s susceptibility to 
HIV-1 infection .  
 
 
Results 
SEA inhibits HIV-1 trans-infection but not cis-infection of CD4
+
 T-lymphocytes 
It has been reported that SEA binds several C-type lectin receptors and competes with 
monomeric HIV-1 gp120 for binding [28,36], but has not been tested for inhibiting HIV-1 
capture and transfer. We confirmed that our derived SEA binds DC-SIGN using a DC-SIGN 
binding ELISA, where increasing concentrations of SEA results in a dose-dependent increase 
of DC-SIGN-Fc binding (Fig 1A). To determine whether this interaction interferes with HIV-
1 binding to DC-SIGN we performed a gp140 competition ELISA. Here DC-SIGN-Fc is 
incubated with SEA before addition to an ELISA plate coated with trimeric gp140. We found 
that concentrations as low as 0.2μg/ml SEA resulted in a 50% reduction of DC-SIGN-Fc 
binding to gp140 (Fig 1B). Since the trimeric gp140 protein closely resembles the functional 
HIV-1 envelope protein, this data suggests that SEA can prevent HIV-1 from interacting with 
DC-SIGN. 
We next tested whether SEA could interfere with HIV-1 cis-infection of CD4
+
 
lymphocytes (direct infection). Therefore, CD4
+
 enriched (CD8
+
 depleted) T-cell blasts were 
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incubated with SEA (1, 5 or 25μg/ml) before HIV-1 SF162 (CCR5 using virus) or LAI 
(CXCR4 using virus) was added. Neither SF162 (R5) nor LAI (X4) viral outgrowth, 
measured as the concentration of HIV-1 capsid protein (CA-p24) in the culture supernatant, 
was affected by the presence of SEA (Fig 1C). This indicates that SEA does not interfere 
with HIV-1 binding to CD4, CCR5 or CXCR4. Additionally, the presence of SEA had no 
visible effect on cell counts and/or cell viability of the CD4
+
 enriched T-cells.  
Since incubating DC-SIGN-Fc with 1μg/ml SEA provided a 70% reduction in its 
capacity to bind gp140 (Fig 1B), we pre-incubated Raji DC-SIGN cells with the same 
concentration to identify whether SEA can block HIV-1 trans-infection of CD4
+
 T-cells. 
Viral outgrowth of both SF162 (R5) and LAI (X4) was approximately 80% reduced in co-
cultures where the Raji DC-SIGN cells were pre-incubated with SEA (p<0.01 and p<0.05, 
respectively) (Fig 1D). Similarly, we tested the effect of SEA on immature monocyte derived 
DCs (iDCs) and observed a significant reduction (p<0.01) in SF162 (R5) outgrowth but only 
when iDCs were pre-incubated with 100μg/ml SEA (Fig 1E). This higher SEA concentration 
was likely required because iDCs express higher levels of DC-SIGN than Raji DC-SIGN 
cells, have multiple other CLRs capable of binding HIV-1 and have a rapid receptor turnover. 
Mannan, known to bind DC-SIGN and block HIV-1 trans-infection, was tested as a positive 
control and provided similar inhibitions (P<0.001). 
SEA consists of many molecules of which IPSE/α-1, kappa-5 (κ5) and omega-1 (ω-1) 
are the major components. To determine whether any of these could be responsible for 
blocking HIV-1 trans-infection, SEA depleted of each product was evaluated using the gp140 
competition ELISA. Depletion of κ5 from SEA partially restored the binding capacity of DC-
SIGN to gp140 whereas depletion of IPSE/α-1 or ω-1 did not abrogate the effect (Fig 1F). 
We next tested whether plant derived recombinant ω-1 (rω-1) or recombinant κ5 (rκ5), which 
carry similar glycosylation profiling as natural derived products [37], could bind to DC-SIGN 
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in the standard binding ELISA assay. SEA showed a dose dependent binding to coated DC-
SIGN as did rκ5 whilst rω-1 demonstrated no binding, supporting the previous finding where 
depletion of natural derived κ5 from SEA removed DC-SIGN binding activity (Fig 1G). 
Furthermore, when testing  rω-1 and rκ5 in a Raji-DC-SIGN mediated capture transfer 
experiment, only rκ5 inhibited HIV-1 infection of CD4+ T-lymphocytes (P<0.05) (Fig 1H).       
In conclusion, SEA potently binds DC-SIGN, via κ5, and prevents DC-SIGN mediated 
capture and transfer of HIV-1 to CD4
+
 T-lymphocytes, whilst having no effect on direct 
infection of CD4
+
 lymphocytes.  
 
SEA exposed DCs induce T-cell cultures with an altered susceptibility to R5 HIV-1 
infection  
Besides the direct effect of blocking HIV-1 trans-infection, SEA may also affect HIV-1 
infection indirectly. SEA exposed DCs have been shown to promote the development of T-
cells that are skewed towards a Th2 phenotype [32]. Since it has been shown that 
differentially skewed Th cell populations have variant HIV-1 infection profiles [12,13] it is 
likely that SEA can modulate HIV-1 infection and/or replication. Here we aimed to i) 
determine whether the presence of SEA during DC maturation alters the polarizing capacity 
resulting in a modified Th cell profile and ii) identify whether such a modulated Th cell 
phenotype has an altered susceptibility for  HIV-1. We therefore established an in vitro model 
system where we could assess the Th cell populations, induced by DCs matured in absence or 
presence of parasite products, for cytokine/chemokine production and HIV-1 infection 
(Schematic shown Fig2A). Here iDCs (donor A) were matured in Th1/Th2 mixed (Tmix)-, 
Th1- or Th2-promoting conditions (LPS, LPS+IFN-γ or LPS+PgE2, respectively) either in the 
absence or presence of SEA. Subsequently, the matured DCs were washed, to remove the 
SEA, and co-cultured with naïve CD4
+
CD45RA
+
 T-cells (donor B) and Staphylococcus 
10 
 
Enterotoxin B (SEB) for 8 days resulting in memory Th cell populations with specific 
phenotypes. These cells were then infected with HIV-1 SF162 (R5) or LAI (X4) and 
monitored for infection over time (Fig 2A and 1S Fig). In our model, Th cell populations 
induced by DC matured under Tmix and Th2 promoting conditions harbour on average 4.4% 
±0.4 and 4.6% ±0.6 SF162
+
 cells, respectively, whilst Th cells induced by DCs matured 
under Th1 promoting conditions have a lower level of infection, 3.1% ±0.7 (P=0.09, 
compared to Tmix cell culture) (Fig 2B, black symbols). When SEA was present during DC 
maturation the percentage of SF162
+
 T-cells was found to be similar in Tmix, Th1 and Th2 
cell cultures, 3.5% ±0.6, 4.6% ±0.9 and 2.8% ±0.5, respectively (Fig 2B, blue symbols). A 2-
way ANOVA revealed that there is a significant interaction (P=0.041) between SEA and the 
Th cell subset infected with SF162, meaning that SEA affects SF162 infection depended on 
the Th cell subset. More in depth analysis of the different groups demonstrated that a Th2 cell 
population induced by SEA exposed DCs have a significantly lower percentage of SF162
+
 T-
cells than a Th2 cell population induced by SEA unexposed DCs (P=0.044). In contrast, SEA 
exposure of DCs inducing Tmix or Th1 populations did not affect the percentage of SF162
+
 T-
cells.  
No such effect was observed in LAI (X4) infected Th cell populations. The percentage 
of LAI
+
 cells in Th cell cultures induced by DCs, matured under Tmix, Th1 and Th2 
promoting conditions, were all found to be similar, 14.4% ±2.2, 16.7% ±4.1 and 12.8% ±1.4, 
respectively, in the absence of SEA or 13.5% ±2.1, 17.8% ±2.5 and 10.6% ±2.4, respectively, 
in the presence of SEA (Fig 2C). Analysing the effect of SEA on infection of different Th cell 
populations using a 2-way ANOVA demonstrated no significant differences. Our data 
demonstrate that the addition of SEA to DCs maturing under Th2 promoting conditions result 
in the induction of a Th cell population with a reduced susceptibility to HIV-1 (R5) infection. 
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Reduced susceptibility of CD4
+
 T-lymphocytes to HIV-1 (R5) via SEA exposed DCs does 
not correlate to altered cytokine/chemokine expression levels 
In order to explain the reduced SF162 (R5) infection in Th2 cell cultures induced by SEA 
exposed DCs we characterized the cytokine/chemokine (IFN-γ, IL-4, IL-2, TNF-α, MIP-1β) 
expression profiles of the different Th cell populations. First we demonstrated that neither 
SF162 (R5) nor LAI (X4) infection alters the potential of the T-cells to produce cytokines in 
Tmix cells (Fig 3A). Next, we determined the effect of exposing DCs to SEA on Th cell 
responses and found a significant reduction of IFN-γ producing T-cells in all three conditions 
irrespective of HIV-1 infection (Fig 3B). Although IL-4 production of the T-cells remained 
similar, the ratio, IL-4/ IFN-γ did increase when T-cells were induced by DCs matured in the 
presence of SEA (Fig 3B and S1 Table). Besides IFN-γ, the percentage of MIP-1β+ cells was 
also significantly reduced in all three T-cell populations where SEA had been present during 
DC maturation (Fig. 3C).  
Interestingly, when comparing the cytokine profile of the SF162 infected (p24
+
) T-cells 
to the profile of the total population we found a higher percentage of IFN-γ and MIP-1β 
producing T-cells in the infected fraction  (for all three T-cell conditions) (Fig. 3D and 3E). 
Analysing the FACS plots revealed it is mainly the percentage of MIP-1β+ and IFN-γ+MIP-
1β+ cells that is enhanced (Fig. 3D). Combining data from several donors shows a significant 
increase in MIP-1β+ and IFN-γ+ cells in the p24+ fraction (P<0.05) (Fig 3F). This increase was 
not observed for IL-4 nor for any cytokine monitored in the LAI (X4) infected fractions (Fig 
3E). However, since this increase in MIP-1β+ and IFN-γ+ cells in the SF162 (R5) infected 
fraction is found in all three T-cell populations induced by SEA exposed DCs it is unlikely 
that this phenomena contributes to the altered SF162 (R5) susceptibility of Th2 cell cultures 
induced by SEA exposed DCs. Hence, the cytokine/chemokine production of the T-cells 
doesn’t explain for the significant reduction in SF162 (R5) infection found in Th2 cell 
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cultures induced by DCs exposed to SEA. Nevertheless, the high percentage of MIP-1β 
producing T-cells in Th1 cell cultures induced by unexposed DCs may explain for the trend 
of reduced of SF162 infection levels in this population (P=0.09) (Fig 2B). 
 
Reduced susceptibility of CD4
+
 T-lymphocytes to HIV-1 (R5) does not correlate with 
altered CCR5 expression  
The reduced HIV-1 infection was only observed for SF162 (R5) and not for LAI (X4), 
suggesting that CCR5 expression levels may be altered in the Th cell populations induced by 
SEA exposed DCs. We determined the percentage of cells expressing CCR5 on the surface as 
well as the quantity of CCR5 per cell. When comparing the Th2 cell cultures induced by 
DCs, either exposed or unexposed to SEA, we found no difference in the percentage of cells 
with a high expression of CCR5, 72% versus 76.6% respectively, as determined by the gate 
based on the marker or the amount of CCR5 expressed on each cell, geometric mean of 1365 
and 1705, respectively (Fig 4A). The interesting finding that the SF162- but not LAI-infected 
fraction had a significantly higher percentage of IFN-γ+ and MIP-1β+ T-cells than the total 
population (Fig 3E) led us to speculate that SF162 (R5) infection resulted in upregulation of 
these cytokines through CCR5 engagement rather than the specific cell phenotype being 
targeted by SF162 (R5) virus. To examine this possibility we added either monomeric SF162 
gp120 or RANTES (a CCR5 ligand) to LAI (X4) infected cultures and determined the 
percentage of IFN-γ and MIP-1β producing T-cells. Addition of monomeric SF162 gp120 (1 
and 3μg/ml) or RANTES (0.7 and 5μg/ml) did not increase the percentage of IFN-γ+ or MIP-
1β+ T-cells compared to 9.3% and 12.8% found in the LAI infected fraction in the absence of 
these compounds (Fig 4B and 4C). Our data indicates that CCR5 signalling is not the cause 
of heightened IFN-γ+ and MIP-1β+ T-cells in the SF162+ fraction. To conclude, we found no 
difference in CCR5 expression between Th2 cell cultures induced by DCs, either exposed or 
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unexposed to SEA. Furthermore, it is unlikely that signalling through CCR5 causes the 
increased percentage of IFN-γ and MIP-1β producing T-cells in the SF162 infected fraction 
compared to the total population.  
 
Recombinant ω-1 (rω-1) exposed DCs induce Tmix cell cultures with a reduced R5 HIV-
1 susceptibility  
Above we demonstrated that Th2 cell cultures induced with SEA exposed DCs, harbour a 
significantly lower percentage of SF162 infected cells compared to Th2 cell cultures induced 
by unexposed DCs. For Tmix cell cultures the average of SF162 infected cells was lower when 
DCs were exposed to SEA, though this difference was not significant. Using increasing 
concentrations of recombinant omega-1 (rω-1), omega-1 being the main Th2 skewing 
component of SEA, on maturing DCs we tried to significantly reduce the percentage of 
SF162 infected T-cells in the induced Tmix cell population [33,34,37].  The presence of 
2µg/ml or 4µg/ml rω-1 during DC maturation resulted in Tmix cell cultures with a reduced 
susceptibility for SF162 (R5) infection, 40% and 60% less cells infected, respectively (Fig 
5A). In contrast, exposing maturing DCs to 1µg/ml did not result in reduced SF162 
susceptibility. Moreover, the presence of rω-1 during DC maturation did not affect the 
induced T-cell population’s susceptibility to LAI (X4) virus. Plotting data from several 
independent experiments confirms that there is significantly less infection with SF162 (R5) 
virus in Tmixcell cultures induced by DCs exposed to rω-1 during maturation, whilst not being 
observed with LAI (X4) infections (Fig 5B).  
Analysing the cytokine/chemokine profile of Tmix cell populations induced by rω-1 
exposed DCs resulted in a similar pattern as observed for T-cell populations induced by SEA 
exposed DCs. There was a significant reduction in the percentage of IFN-γ and MIP-1β 
producing T-cells whilst the percentage of IL-4 producing cells remained unaltered (Fig 5C). 
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Based on the cytokine/chemokine profile of these cells it does not appear that rω-1 leads to 
enhanced Th2 skewing. What we did find was a modest, 10%, reduction in the percentage T-
cells with a high expression of CCR5 (indicated by the gate based on the marker) in Tmix cell 
cultures induced by rω-1 exposed DCs as well as a reduced level of CCR5 surface expression 
per cell, geometric mean of 1,209 versus 2,063, respectively which potentially plays a role in 
the reduced infection with R5 virus (Fig 5D). Collectively, these results indicate that ω-1 is 
the component responsible for the reduced SF162 (R5) infection observed in Th2 cell 
populations induced by SEA exposed DCs.  
 
 
Discussion  
Helminthic parasites are known to possess immunomodulatory properties and specifically 
skew immune responses towards a Th2 phenotype [32]. Here we studied the effect’s SEA had 
on modulating HIV-1 infection in vitro. Although SEA did not affect cis-infection of CD4
+
 
enriched T-cell blasts it efficiently blocked DC-SIGN mediated HIV-1 trans-infection 
through the binding of Kappa-5 to DC-SIGN. We demonstrated that exposing DCs maturing 
under Th2 promoting conditions to SEA induce Th cells that were less susceptible to R5 but 
not X4 infection and that recombinant ω-1 (rω-1), possessed the same activity with DCs 
maturing under Tmix promoting conditions. Collectively, our data demonstrates that SEA has 
the capacity to influence numerous mechanisms associated with HIV-1 transmission and 
pathogenesis, suggesting that the S. mansoni infection has the potential to modulate HIV-1 
infection as well as disease course. 
Receptive anal intercourse carries the highest high risk for HIV-1 transmission, likely 
due to the nature of the mucosal barrier and the immune cells residing at this site [2,38]. DCs 
will be amongst the first cells encountering HIV-1 with the potential of transferring virus to 
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CD4
+
 T-lymphocytes either locally or in adjacent lymph nodes [5]. The presence of SEA in 
the gut wall may therefore influence trans-infection and interfere with the transmission 
process. Similarly, Th cell responses induced in localised lymph nodes by DCs exposed to 
SEA, more so ω-1, could have a phenotype that is less susceptible to infection with R5 HIV-
1, again limiting the likelihood of transmission [39]. Moreover, regardless of the route of 
HIV-1 infection a massive loss of CD4
+
 memory T-lymphocytes in the GALT is observed 
within the first few weeks of infection [4]. This reservoir is not replenished after peak viremia 
and although the initial cell loss is not correlated with HIV-1 disease progression, microbial 
translocation caused by loss of the GALTs function is [4,40]. The potential reduction in HIV-
1 infection of GALT tissue exposed to SEA/ω-1 may therefore reduce not just cellular 
infection profiles but also the effects of bacterial translocation.  
Several cytokines and CC-chemokines have been associated with alterations in HIV-1 
infection and disease progression. MIP-1α, MIP-1β and RANTES are the natural ligands for 
CCR5, hence in vitro T-cell cultures containing high levels of these chemokines have lower 
levels of HIV-1 R5 infection [41,42] as has been observed ex vivo [17]. In contrast, we 
observed a significantly lower percentage of Th cells capable of producing IFN-γ and MIP-1β 
when they were induced by DCs matured under Tmix, Th1 or Th2 promoting conditions in the 
presence of SEA or rω-1 (Fig 3C and 5C). The HIV-1 R5 infected fraction however, had a 
higher percentage of Th cells producing IFN-γ and MIP-1β then the total population. This 
suggests that either these cells were targeted or IFN-γ and MIP-1β were induced upon HIV-1 
R5 infection. Addition of monomeric HIV-1 R5 gp120 or recombinant RANTES to HIV-1 
X4 infected cell cultures did not induce a similar effect, suggesting the latter is not the case. 
Targeting of these cells seems equally unlikely since MIP-1β competes with HIV-1 R5 for 
CCR5 binding [12,42-44]. HIV-1 R5 may induce IFN-γ and MIP-1β via another mechanism, 
for example some forms of the viral protein nef induce MIP-1β production in macrophages 
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[45,46] while the viral protein Tat can induce MIP-1β secretion by neural progenitor cells 
[47]. Although it may seem counter intuitive that HIV-1 infection stimulates expression of 
MIP-1β,  the function of this chemokine is to recruit CD4+ T-lymphocytes to the site of 
infection. Thereby enhancing the number of target cells for HIV-1 replication [48]. It has also 
been shown that IL-2
+
 expressing cells are rapidly lost as a consequence of HIV-1 infection 
due to high levels of infection [17,49]. Since IL-2 is added to our cell culture system to 
ensure T-cell survival, we are unable to analyse the effects of IL-2 on HIV-1 infection with 
our system. 
Besides cytokines and chemokines, we explored whether differences in surface 
expression levels of CCR5 could explain reduced infection with HIV-1 R5 but not X4. In Th2 
cell cultures induced by SEA exposed DCs we found similar percentages of cells expressing 
CCR5 and similar levels of CCR5 on the surface of each cell (geometric mean) compared to 
Th2 cell cultures induced by unexposed DCs. As observed with SEA, rω-1 also reduced the 
DCs capacity to produce cytokines and co-stimulatory molecules in response to stimulus [33-
35]. The mechanism via which a Th2 response is induced is still unknown, with one 
hypothesis being that the lack of stimuli provided by the DCs to the naïve T cells pushes 
them into default mode, namely Th2 phenotype [35,50,51]. Yet, rω-1 exposed DCs induced 
Tmix cell cultures which had even lower levels of HIV-1 R5 infection and which had a 
reduced percentage of cells expressing CCR5 as well as a reduced level of CCR5 per cell. 
Consequently, although CCR5 is not the main mechanism responsible for reduction in HIV-1 
R5 infection it will likely contribute to the overall reduction of infection observed in Tmix cell 
cultures induced by DCs exposed to rω-1. 
There are several hypotheses to explain for the reduced infection of CD4
+
 T-
lymphocytes, one of which is the capacity of SEA and rω-1 exposed DCs to induce 
regulatory T (Treg) cells [52,53]. Treg cells are susceptible to HIV-1 although several studies 
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demonstrate that infection is restricted. It has been demonstrated that Treg cells were less 
susceptible to HIV-1 (R5) infection than effector memory T-lymphocytes while X4 viruses 
gave higher or similar levels of infection [54]. Further comparisons revealed these cells 
expressed similar levels of CD4, CCR5 and CXCR4 on their surface and produced similar 
levels of CC-chemokine production. Although no explanation was provided, the cellular 
activation status as well as FoxP3 interference pattern were thought to play a role. Some 
studies support the notion that FoxP3 inhibits HIV-1 infection by interfering with HIV-1’s 
LTR transcription activation [55,56] while others demonstrate enhanced HIV-1 production in 
FoxP3 positive cells [57,58]. The role of FoxP3 seems to be dependent on the viral strain as 
well as the culture protocol used for the cells. Another hypothesis is that virus production 
may be limited but not susceptibility [59], or that viral restriction factors, such as 
APOBEC3G may limit infectivity [60]. Further phenotypic characterisation of T-cells 
induced by SEA exposed DCs and more specifically rω-1 will undoubtedly associate 
additional cellular differentiation markers that associate with HIV-1 infection and/or 
replication with potential implications for induction of viral latency.  
As well as SEA and rω-1 driving the induction of Th2 phenotypes [32-35] SEA has 
been shown to down-modulate DC TLR4 as well as LPS induced signalling [30]. More in-
depth analysis with human DCs has demonstrated that SEA exposed DCs have enhanced 
expression of the negative regulators SOCS1 and SHP1 which result in impaired DC 
maturation and induction of CD4
+ 
lymphocyte proliferation [61]. Similarly, in a murine 
model system it has been shown that SEA treated DC possess impaired LPS mediated 
maturation as identified through reduced expression of co-stimulatory molecules [62]. Our 
results support these findings and indicate that SEA/rω-1, through interacting with DCs, can 
induce CD4
+
 lymphocytes responses with reduced proliferative/activation phenotypes with 
potential consequences for HIV-1 infection and/or replication.  
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Reduced infection of CD4
+
 T-lymphocytes with R5 but not X4 HIV-1 may restrict 
initial viral replication or slow the rate at which HIV-1 switches its co-receptor phenotype. 
Large scale monitoring of study cohorts would need to be performed to identify whether such 
effects indeed do exist and which would undoubtedly be limited by factors such as parasite 
loads and corresponding egg counts. This complexity is confirmed by the discrepancies found 
in epidemiological studies of co-infected individuals [21,22]. The findings that HIV-1 R5 
viruses replicated better in Th2 than Th1 cells resulted in the interpretation that treating S. 
mansoni infection may benefit co-infected patients [20,21]. Whether this can correlate to the 
in vivo setting needs to be determined. As always with such findings antigenic concentration 
and the localisation of the source will be instrumental in determining to what capacity. The 
effects of helminthic infections have been shown to dampen immune inflammatory responses 
with considerable consequences for diseases associated with such effects [63]. This would 
suggest that SEA antigens, including κ5 and ω-1, possess the physiological capacity to 
influence HIV-1 infection and disease. These skewing effects have ultimately to be 
considered in the context of parasite antigens having the capacity to activate immune 
responses which provides a complex balance where different antigens have variant effects 
within co-infected individuals. We provide evidence here that Th cells induced by SEA/rω-1 
exposed DCs are less susceptible to R5 HIV-1 infection, suggesting that helminthic infections 
may be beneficial when considering HIV-1. Deciphering the mechanisms may provide a 
means towards modulating immune responses beneficial for limiting viral transmission or 
reducing viral loads. Furthermore, these results should be considered in the context of HIV-1 
vaccine trials being conducted in regions of the world where S. mansoni infections are 
endemic.    
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Materials and Methods  
Parasitic products 
SEA was prepared and isolated as described previously [32]. Kappa-5 (κ5) was isolated by 
soybean agglutinin (SBA; Sigma, Zwijndrecht, the Netherlands) affinity chromatography as 
described previously [64]. The remaining SEA fraction was labeled as κ5 depleted SEA. 
Omega-1 and IPSE/alpha-1 were purified from SEA via cation exchange chromatography as 
previously described [35,49,65]. Omega-1 was then separated from IPSE/alpha-1 by affinity 
chromatography using specific anti-IPSE/alpha-1 monoclonal antibodies coupled to an NHS-
HiTrap Sepharose column according to the manufacturer's instructions (GE Healthcare). 
Purified components were concentrated and dialyzed. Omega-1–depleted SEA or IPSE-
depleted SEA were prepared by adding back purified IPSE/alpha-1 or omega-1, respectively, 
to the remaining SEA fraction left from the cation exchange chromatography. The purity of 
the preparations was controlled by SDS-PAGE and silver staining. Protein concentrations 
were tested using the Bradford or BCA procedure [66]. Plant produced rω-1 and rκ5 were 
purified from apoplast fluid using HS POROS 50 strong cation exchange (CEX) resin 
(Applied Biosystems) as previously described [34]. Apoplast fluids were transferred over 
G25 Sephadex columns to exchange for CEX binding buffer (20 mM phosphate buffered 
saline (pH 6.0) containing 100 mM NaCl). The plant derived rω-1 and rκ-5 molecule is 
similar to helminthic derived proteins with similar post-translational modifications, 
specifically glycosylation profiling, as observed in parasites.   
 
Viruses 
SF162 (R5), BAL (R5) and LAI (X4) are replication competent HIV-1 subtype B viruses. 
SF162and BAL are molecular cloned isolates obtained from HIV-1 infected patients and 
which utilise CCR5 as co-receptor. LAI represents a molecular cloned virus isolated from an 
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HIV-1 infected patient and utilises the CXCR4 co-receptor for infection. Viruses were 
passaged on CD4
+
 enriched T lymphocytes and tissue culture infectious dose (TCID50) values 
were determined by limiting dilutions on CD4
+
 enriched T-lymphocytes according to the 
Reed and Muench method, as previously described [67].  
 
ELISA assays 
The DC-SIGN binding ELISA was performed as described [10]. Briefly, the components of 
interest (SEA, rω-1 or rκ5) were coated at 5 fold dilutions (50µg/ml – 0.01µg/ml on an 
ELISA plate after which 333ng/ml DC-SIGN-Fc (R&D systems) was added. Subsequently, 
DC-SIGN-Fc was detected by a secondary goat-anti-human-Fc HRP labelled antibody 
(Jackson Immunology), diluted 1:1000 and using standard ELISA procedures. In the gp140 
competition ELISA, 10µg/ml anti-HIV-1 gp120 antibody D7324 (Aalto BioReagents Ltd) 
was coated on an ELISA plate after which trimeric HIV-1 gp140 (JR-FL SOSIP.R6-IZ-
D7324) was added to the plate as previously described [68,69]. Meanwhile 333ng/ml DC-
SIGN-Fc (R&D systems) was incubated with SEA at limiting dilutions. Next, the mixture 
was added to the gp140 coated plate and using a secondary HRP labelled goat-anti-human-Fc 
antibody (Jackson Immunology) diluted at 1:1000, DC-SIGN-Fc binding to the gp140 plate 
was determined. A more detailed description can be found [68]. The Capsid p24 ELISA was 
performed as standard [8]. In short, an ELISA plate was coated O/N with 10µg/ml sheep anti-
p24-specific antibody (Aalto Bio Reagents Ltd.). Culture supernatant was added, followed by 
4ng/ml mouse anti-HIV-1-p24 alkaline phosphatase conjugate antibody (Aalto Bio Reagents 
Ltd.). As development solution Lumi-phos plus (Lumigen Inc.) was used according to the 
manufacturer's protocol. The standard curve consists of a serial dilution of Escherichia coli-
expressed recombinant HIV-1-p24 (Aalto Bio Reagents Ltd.).  
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Cell lines and primary cell isolation 
Raji DC-SIGN cells (a kind gift from Prof TBH Geijtenbeek, University of Amsterdam), an 
immortalized B cell line stably transfected with DC-SIGN [5] was cultured in RPMI 1640 
(Invitrogen) supplemented with 10% FCS, 100U/ml penicillin and 100U/ml streptomycin. 
Peripheral blood mononuclear cells (PBMCs) were isolated using ficoll-hypaque density 
centrifugation from buffy coats purchased from the Netherlands Blood bank (Sanquin). 
PBMCs of three CCR5 wild-type homozygous donors were pooled and cultured in RPMI 
1640 containing 10% FCS, 100U/ml penicillin, 100U/ml streptomycin, 100U/ml recombinant 
IL-2 and cells were activated with 2µg/ml phytohemagglutinin (PHA) (Sigma). To enrich for 
CD4
+
 T-lymphocytes, the CD8
+
 T-lymphocyte population was removed using CD8 
dynabeads (Life Technologies) according to manufacturer’s protocol at day 5. These cells 
were used for experiments depict (Fig 1), as for the remaining experiments cells were isolated 
from fresh blood.  
Monocytes were isolated from fresh blood using lymphoprep (Nycomed) and 
subsequent percoll (GE Healthcare) density gradient (34, 47,5 and 60% of standard isotone 
percoll) centrifugation. For 6 days, monocytes were cultured in IMDM (Gibco) containing 
5% FCS, 86μg/ml gentamycin (Duchefa), 500U/ml GM-CSF (Schering-Plough) and 10U/ml 
IL-4 (Miltenyi) differentiating them into immature DCs (iDCs). From the PBMC fraction the 
CD4
+
 T-cells were isolated using the CD4 T-cell isolation MACS kit (Miltenyi Biotec., 130-
091-155) according to manufacturer’s protocol. Subsequently, the CD4+CD45RA+CD45RO- 
naïve T-cells were isolated from the CD4
+
 T-lymphocytes using anti-CD45RO-PE (DAKO, 
R084301) and anti-PE beads (Miltenyi-Biotec, 130-048-801), described in detail [70]. 
 
HIV-1 cis-infection assay 
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CD4
+
 enriched T-cells (2x10
5 
cells/well) were incubated with 25, 5 or 1 μg/ml SEA or 
medium (control) for 2h in a 96-well flat-bottomed culture plate (Greiner Bio-One), 
subsequently medium, SF-162 (TCID50/ml of 200) or LAI (TCID50/ml of 200) was added to 
the well. At day’s 4, 7 and 12 supernatants were harvested and cells feed with fresh media, 
HIV-1 capsid p24 was determined in the supernatants using a standard ELISA protocol. 
 
HIV-1 trans-infection assay 
Raji DC-SIGN cells (5x10
4
 cells/well) were pre-incubated with 1μg/ml SEA for 2h after 
which SF162 (R5) or LAI (X4) viruses were added at an end concentration of 200 
TCID50/ml. After a further 2h incubation the cells were washed 3 times with PBS and co-
cultured with enriched CD4
+
 T-lymphocytes (2x10
5
 cells/well). Viral outgrowth was 
measured by monitoring capsid p24 at day 4, 7 and 12 in harvested culture supernatant. HIV-
1 capture/transfer by iDCs was conducted in a similar manner with minor modifications; 20 
or 100 μg/ml SEA was utilized and the incubation steps were shortened to 30min.  
 
T-lymphocyte outgrowth model system  
A co-culture system was developed where monocytes were pre-incubated with immune 
skewing reagents in the presence or absence of parasite product (SEA or rω-1), before 
washing and adding to isolated memory T-cells and subsequently monitoring HIV-1 infection 
profiles or markers of CD4 cell phenotype. Typically, iDCs from donor A were matured for 2 
days with 100ng/ml LPS (Sigma-Aldrich) (which typically generates DCs that induce a 
Thmix-cell phenotypes), 100ng/ml LPS and 100U/ml IFN-γ (UCytech) (which typically 
generates DCs that induce a Th1-cell phenotype) or 100ng/ml LPS and 10μM PgE2 (Sigma-
Aldrich) (which typically generates DCs that induce a Th2-cell phenotype) either in the 
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absence or presence of 25μg/ml SEA or 1- 4μg/ml rω-1. After thoroughly washing the 
matured DCs 3 times, 5x10
3
 of cells were co-cultured with 2x10
4
 CD4
+
CD45RA
+
CD45RO
-
 
T-cells (naive) from donor B in 96-well flat bottom culture plates and 10pg/ml
 
Staphylococcus enterotoxin B (Sigma-Aldrich) in IMDM, 10% FCS, 86μg/ml gentamycin 
(Duchefa). Cells were split at day 5 and day 7 with 20U/ml IL-2 being added to the medium. 
At day 8, 5x10
4
 cells/well were plated on 96-well flat bottomed plates and infected with 
SF162 (TCID50/ml 1000) or LAI (TCID50/ml 200). Since iDCs don’t survive this length of 
time in culture under these conditions the measured levels of infection represent direct cis-
infection of Th-cells. Day 5 and 7 post-infection cells were re-stimulated for 6h with 10ng/ml 
PMA (Sigma-Aldrich), 1μg/ml ionomycin (Sigma-Aldrich), 10μg/ml brefeldin A (Sigma-
Aldrich) supplemented with 0.1μg/ml T1294 (Pepscan Therapeutics BV) to prevent new 
infections during this period. Subsequently, cells were fixed in 3.7% formaldehyde and stored 
for no more than 1 week at 4⁰C in FACS buffer (PBS+ 2%FCS) for flow cytometry analysis, 
measuring intracellular viral p24 antigen as well as an array of cell surface markers or 
intracellular cytokines/chemokines. Experiments where monomeric gp120 (SF162) (Immune 
Technology Corp.) or RANTES (Sigma-Aldrich) were added were conducted similarly. 
These compounds (concentrations in text) were added to the T-cell culture 24h after LAI 
infection and four days later the cells were re-stimulated. Experiments with SEA show the 
results of at least five different donor combinations and for experiments using rω-1 four 
different donor combinations are depict in figures (see respective Fig legends). 
 
Flow cytometry 
To measure intracellular activation markers cells were permeabilized for 30 minutes with 
PermWash at RT (BD Pharmingen) and subsequently stained with p24-PE (Beckman 
Coulter) and IFN-γ-FitC, IL2-PerCp-Cy5.5, IL-4-APC, TNF-α-PE-CF594, Mip-1β-
24 
 
AlexaFluor700 (all from BD Bioscience) for 30min at 4⁰C at a pre-determined dilution. Next, 
these cells were washed once with PermWash and taken up in FACS buffer (PBS+ 2%FCS) 
after which they were analyzed using a FACS Canto II machine. For determining CCR5 
surface expression, T-cells obtained from our T-cell outgrowth model were fixed in 3.7% 
formaldehyde before HIV-1 infection and stored for no more than 1 week at 4⁰C in FACS 
buffer. These cells were stained in FACS buffer with CCR5 PE-Cy7 (Biolegend) for 30min at 
RT, washed with FACS buffer and measured. Depict in histograms are cytokine producing T-
cells with samples taken 5 and 7 days after HIV-1 infection with the optimal time point being 
determined by the percentage of live cells (>50%) and level of HIV-1 infection, which varied 
per donor and per virus. Gating strategies and flow cytometric controls are represented in 
(Suppl. Fig 2) and (Suppl Fig 3), respectively. 
 
Ethics Statement 
All cells were isolated from anonymized buffy coats purchased through the Nederlands Blood 
Bank (Sanquin) where IRB approval was granted and donors signed a specifically consented 
in the additional use of samples for research purposes as outlined in the research contract 
between the AMC and Sanquin (number NVT0202.02). 
 
Statistical analysis 
Data was analysed by an unpaired t-test when comparing two groups and a 1-way ANOVA 
when comparing several groups (Fig 1). For the remaining figures the data is corrected for the 
systematic differences between donors using factor correction [71]. Subsequently, within 
each specific T-cell population the effect of induction with SEA/rω-1 exposed or unexposed 
DCs was compared using a paired T-test whereas data between two T-cell population’s data 
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was compared using an unpaired T-test. Additionally for figure 2, a 2-way ANOVA was 
performed to determine whether there was an interaction between the T-cell population 
infected and the usage of SEA. 
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Figure Legends 
Fig 1. SEA binds DC-SIGN and can block trans-infection of CD4 T-lymphocytes but not 
cis-infection. (A) DC-SIGN binding ELISA where DC-SIGN-Fc was added to 5 fold serial 
dilutions of SEA coated onto an ELISA plate, the highest OD450 was set to 100% binding 
with ±SEM shown. (B) A gp140 competition ELISA where DC-SIGN-Fc was incubated with 
serial dilutions of SEA for 30min at RT prior to addition to a trimeric gp140 coated ELISA 
plate (captured via an HIV-1 Env antibody). The highest OD450 was set to 100%, implying 
that 0.01μg/ml SEA will not block DC-SIGN-Fc binding to gp140. (C) Effect of SEA on cis-
infection was determined by adding SEA 2h prior to SF162 (R5) or LAI (X4) to CD4
+
 
enriched T-lymphocytes. Viral outgrowth was monitored through measuring p24 levels in 
culture supernatant at either day 5 or 7 of infection. (D) SEA’s effect on trans-infection was 
determined by pre-incubating Raji DC-SIGN cells with 1μg/ml SEA for 2h and subsequently 
adding SF162 (TCID50 5000) or LAI (TCID50 500). Viral outgrowth in Raji DC-SIGN - 
CD4
+
 T-lymphocyte co-cultures was monitored through measuring p24 levels in culture 
supernatant. (E) Similarly, iDC were incubated with SEA or mannan (positive control) for 
30min prior to addition of SF162 (TCID50 200). Viral outgrowth in iDC - CD4
+
 T-
lymphocyte co-cultures was monitored through measuring p24 levels in culture supernatant at 
either day 5 or 7 of infection. (F) SEA components rκ5 (1.7g/ml), IPSE or rω (both 2μg/ml) 
were examined in the gp140 competition ELISA. The OD450 of DC-SIGN-Fc binding to 
gp140 is set to 100% and binding of SEA pre-incubated DC-SIGN-Fc is plotted as a 
percentage of this 100%. Pre-incubating DC-SIGN-Fc with any of the SEA fractions or 
mannan resulted in a significant decrease (p<0.05) in gp140 binding. (G) SEA as well as rω-1 
or rκ5 were coated at limiting dilution on an ELISA plate and analysed for DC-SIGN-Fc 
binding. (H) Recombinant protein effects on trans-infection were determined by pre-
incubating Raji DC-SIGN cells with rω-1 (10 µg/ml) or rκ5 (10 µg/ml) for 2h and 
36 
 
subsequently adding BAL (TCID50/ml 1000) or LAI (TCID50/ml) virus followed by enriched 
CD4
+
 lymphocytes and measuring p24 levels in culture supernatant on day 5. (B-H) 
Experiments were performed in triplicate and data shown as mean of these triplicates with 
±SD. *p< 0.05,**p<0.01, ***p<0.001. 
 
Fig 2. HIV-1 SF162 (R5) infection is altered in T-cell cultures induced by SEA exposed 
DCs. (A) Schematic overview of our in vitro model system. Isolated iDCs are matured under 
Tmix, Th1 or Th2 promoting conditions either in absence or presence of parasite antigen. 
Subsequently, the matured DCs were co-cultured with naïve CD4
+
 T-cells in combination 
with Staphylococcal Enterotoxin B (SEB). The induced effector memory T-cell populations 
(Tmix, Th1 or Th2 cell cultures) were then infected with HIV-1 after which, among others, the 
percentage of HIV-1 infected cells was measured. (B) Percentage of SF162
+
 cells in Tmix, 
Th1 and Th2 cell cultures induced by DCs unexposed (black) or exposed to SEA (blue). (C) 
Percentage of LAI
+
 cells in Tmix, Th1 and Th2 cell cultures induced by DCs unexposed 
(black) or exposed to SEA (red). (B and C) Results of 6 to 8 independent experiments using 
at least 5 different donors combined and depict are the mean value and SEM. 
 
Fig 3. DCs exposed to SEA, induce T-cell cultures with less IFN-γ and MIP-1β 
producing T-cells. (A) Percentage of Tmix-cells producing IFN-γ, MIP-1β and IL-4 in an 
uninfected (bar 1), SF162 (bar 2) or LAI (bar 3) infected T-cell population., Representative 
for Tmix, Th1 and Th2 cell cultures induced by DCs matured either in absence or presence of 
SEA. (B) Plotted is the average percentage of IL-4 and IFN-γ producing T-cells in Tmix, Th1 
and Th2 cell cultures induced by DCs matured either in absence or presence of SEA. (C) 
Average percentage of MIP-1β producing T-cells in the three T-cell populations induced by 
DCs matured in absence or presence of SEA. (D) Dot-plot of IFN-γ (y-axis) and MIP-1β (x-
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axis) producing Th1 cells in the SF162 population (left) and the p24
+
 fraction of that 
population (right) shown in the next panel. (E) Percentage of IFN-γ, MIP-1β and IL-4 
producing T-cells in a SF162 or LAI infected Th1 cell culture (bar 1 and 3) versus the 
percentage found in the p24
+
 fraction (bar 2 and 4). (F) Data of 7 independent experiments 
combined depicting the percentage of IFN-γ and MIP-1β producing T-cells in a SF162 
infected Th1 cell population versus the percentage found in the p24
+
 fraction of that 
population. Both Figs (E and F) are representative for all three T-cell populations induced by 
DCs matured either in absence or presence of SEA. (A, D, E) Representative figures from at 
least 5 experiments (conditions with virus were performed in duplicate) while (B, C, F) are 
the results of 6 to 8 independent experiments using at least 5 donor combinations combined, 
depict are the mean value and SD. *p<0.05 **p<0.01 ***p<0.001. 
 
Fig 4. CCR5 expression does not correlate with altered SF162 infection. (A) Th2 cell 
cultures induced by DCs matured in absence or presence of SEA (dotted line unstained 
control) , analysed for the percentage of cells with high levels of CCR5 on their surface as 
well as the quantity of CCR5 on the surface of each cell (geometric mean). (B) Dot-plots 
showing the percentage of IFN-γ (y-axis) and MIP-1β (x-axis) producing T-cells in the LAI+ 
fraction of LAI infected cultures (left), LAI infected cultures with 1μg/ml (middle) or 3μg/ml 
(right) monomeric SF162 gp120 added 24h after LAI infection. (C) Dotplots showing 
percentage of IFN-γ (y-axis) and MIP-1β (x-axis) producing T-cells in the LAI+ fraction of 
LAI infected cultures (left), LAI infected cultures with 0.7μg/ml (middle) or 5μg/ml (right) 
RANTES added 24h after LAI infection. (A-C) Are representative figures of experiments 
performed at least 3 times.  
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Fig 5. Rω-1 exposed DCs induce a Tmix cell population less susceptible for SF162 (R5) 
but not LAI (X4) infection. (A) Percentage of SF162 or LAI infected cells in Tmix cell 
populations induced by rω-1 unexposed DCs was set to 100% and the level of infection found 
in Tmix cell cultures induced by rω-1 exposed DCs was expressed as a percentage of this 
100%. (B) The percentage of SF162
+
 cells found in Tmix cell populations induced by 
unexposed DCs versus the percentage found Tmix cell populations induced by rω-1 exposed 
DCs (left panel) with +/- SE shown. Same for LAI (right panel) with +/- SE shown. (C) 
Average percentage (± SEM) of IL-4, IFN-γ and MIP-1β producing T-cells in Tmix cell 
cultures induced by unexposed or rω-1 exposed DCs and depict with SD. (D) Percentage of 
cells with high CCR5 expression on their surface as well as the quantity of CCR5 per cell 
(geometric mean) for Tmix cell cultures induced by unexposed or rω-1 exposed DCs (dotted 
line unstained control), representative figure of 3 independent experiments. (B, C) Data from 
four independent experiments (± SD) using four different donor combinations where DCs 
were matured in the presence of 2-4μg/ml rω-1.  
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Supplementary Figure and Table legends 
Supplementary Fig 1. Th1/Th2 ratio in the different T-cell cultures. Depicted are dot-
plots showing the percentages of IL-4 (y-axis) and IFN- (x-axis) producing T-cells in the Tmix 
(left), Th1 (middle) and Th2 (right) cell cultures of a typical experiment. 
 
Supplementary Fig 2. Gating strategy and controle staining for p24+ cells and intracellular 
cytokine stainings. (A) Gating of p24+ cells was performed using a live cell gate using FSC 
and SSC (left panel), a single cell gate using FSC width  (middle panel) and a p24+ cell gate 
(right panel). (B) Single staining’s for IFNγ (left), IL-4 (2
nd
 left), MIP-1α (3
rd
 left) and p24 
(right) of T cells restimulated with PMA and ionomycine for 6 hrs in the presence of 
Brefeldin A. Markers are set on positive cells and used for subsequent analysis of T cell 
phenotype. 
 
Supplementary Table 1. Ratio of IL-4 and IFN-γ in various cell cultures. Here the ratio 
of IL-4 and IFN-γ for each cell culture induced DCs matured in absence or presence of SEA 
is demonstrated. 
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